Emphasis on Type (23mm, 26mm, and 29mm.); End-User (Hospitals, Ambulatory Surgical Centers, and Others); Region/Country.
The balloon valvuloplasty device market was valued at USD 2251.18 Million and is expected to grow at a strong CAGR of around 4.7% during the forecast period (2023-2030) owing to rising prevalence of cardiovascular diseases. According to the CDC, cardiovascular diseases are the leading cause of death in the United States. Each year, around 647,000 Americans die from heart diseases, accounting for approximately one in every four deaths. This statistic highlights the alarming prevalence of CVD, necessitating effective treatment options like balloon valvuloplasty devices. The NHLBI provides valuable data on the prevalence of heart valve diseases in the US. Based on their estimates, around 5 million Americans suffer from heart valve diseases, including valve stenosis, indicating a significant patient population that requires treatment. Balloon valvuloplasty devices play a crucial role in managing these conditions without the need for open-heart surgery.
Some of the major players operating in the market Medtronic plc; Terumo Corporation; Boston Scientific Corporation; Abbott; Edwards Lifesciences Corporation; B. Braun; BD; BVM MEDICAL LTD; TORAY INDUSTRIES, INC.; and Balton. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst type, the 29mm category to grow with significant CAGR during the forecast period”
On the basis of type, the market is categorized into 23mm, 26mm, and 29mm. The 29mm category is anticipated to grow with high CAGR during the forecast period. 29mm balloon valvuloplasty device devices are medical devices used for the treatment of certain heart conditions called valvular stenosis. Valvular stenosis occurs when one or more heart valves become narrowed or blocked, reducing blood flow through the heart. This can lead to various symptoms such as shortness of breath, fatigue, and chest pain. The 29mm balloon valvuloplasty device is specifically designed for patients who require a larger diameter balloon to dilate their stenotic heart valve. It is a minimally invasive procedure that involves inserting a deflated balloon catheter into the affected valve through a blood vessel, usually the femoral artery in the groin. The balloon is then inflated to stretch and open the narrowed valve, improving blood flow.
“Amongst end-user, the hospitals category to grow with significant CAGR during the forecast period”
On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers, and others. The driving factors for the hospitals are numerous and include the prevalence of the disease, the advancement of treatments and technology, the quality of care provided, the availability of specialized physicians and skilled nursing staff, and the financial incentives offered by health insurance companies. The hospitals offer treatment to a large number of patients, allowing them to capitalize on economies of scale and offer more efficient and cost-effective services. Financial incentives from health insurance companies are also a major factor, as these can reduce the cost of treatment and make it more affordable for patients.
Balloon Valvuloplasty Device Market Report Coverage
“APAC to grow with high CAGR during forthcoming ”
APAC is anticipated to grow with high CAGR during the forthcoming period. Firstly, the increasing prevalence of cardiovascular diseases, particularly valvular heart diseases, is contributing to the demand for balloon valvuloplasty devices. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, accounting for nearly 17.9 million deaths annually. Moreover, the rapid approval from Chinese government is also having a positive impact on the market’s growth. For instance, in May 2020, Peijia Medical received approval from the National Medical Products Administration of the PRC for the registration application of Fastunnel Delivery Balloon Dilation Catheter (formerly named Neway Balloon Microcatheter), making it the Group’s thirteenth NMPA approved neurointerventional product.
Reasons to buy this report:
Customization Options:
The global balloon valvuloplasty device market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1. Market Introduction
2. Research Methodology Or Assumption
3. Market Synopsis
4. Executive Summary
5. Global Balloon Valvuloplasty Device Market Covid-19 Impact
6. Global Balloon Valvuloplasty Device Market Revenue, 2020-2030f
7. Market Insights By Type
8. Market Insights By End User
9. Market Insights By Region
10. Balloon Valvuloplasty Device Market Dynamics
11. Balloon Valvuloplasty Device Market Opportunities
12. Balloon Valvuloplasty Device Market Trends
13. Demand And Supply-side Analysis
14. Value Chain Analysis
15. Competitive Scenario
16. Company Profiled
17. Disclaimer
Research Methodology for the Balloon Valvuloplasty Device Market Analysis (2023-2030)
Analyzing the historical market, estimating the current market, and forecasting the future market of the global balloon valvuloplasty device market were the three major steps undertaken to create and analyze the adoption of balloon valvuloplasty device in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global balloon valvuloplasty device market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the balloon valvuloplasty device market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the balloon valvuloplasty device market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as type, and end-user. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the balloon valvuloplasty device market. Further, we conducted factor analysis using dependent and independent variables such as type, and end-user of the balloon valvuloplasty device market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the balloon valvuloplasty device market sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global balloon valvuloplasty device market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global balloon valvuloplasty device market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the type, and end-user in the global balloon valvuloplasty device market.
The main objective of the Global Balloon Valvuloplasty Device Market Study
The current & future market trends of the global balloon valvuloplasty device market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:
Q1: What is the current market size and growth potential of the global XX market?
Q2: What are the driving factors for the growth of the global balloon valvuloplasty device Market?
Q3: Which segment has the largest share of the global balloon valvuloplasty device market by Type?
Q4: What are the emerging technologies and trends in the global balloon valvuloplasty device market?
Q5: Which region will dominate the global balloon valvuloplasty device market?
Q6: Who are the key players operating in the global balloon valvuloplasty device market?
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
